We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$693M
AUM Growth
-$53.2M
Cap. Flow
+$17M
Cap. Flow %
2.45%
Top 10 Hldgs %
46.29%
Holding
382
New
110
Increased
31
Reduced
28
Closed
176

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$32.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$18.7M
3
DIS icon
Walt Disney
DIS
+$14.1M
4
TSM icon
TSMC
TSM
+$6.86M
5
AMZN icon
Amazon
AMZN
+$6.38M

Sector Composition

Rank Sector Weight
1 Technology 13.91%
2 Communication Services 5.2%
3 Healthcare 1.02%
4 Materials 0.39%
5 Utilities 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIS
151
PUT
Nebius Group N.V.
NBIS
$37.6B
$246K 0.04%
13,000
-3,000
-19% -$56.8K
ASND icon
152
Ascendis Pharma A/S
ASND
$16.5B
$244K 0.04%
+2,000
New +$232K
FOLD
153
PUT
DELISTED
Amicus Therapeutics
FOLD
$244K 0.04%
+20,000
New +$225K
MRTX
154
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$227K 0.03%
5,000
-1,300
-21% -$84.1K
VTRS icon
155
Viatris
VTRS
$20.8B
$223K 0.03%
20,000
+5,000
+33% +$52.3K
VTRS icon
156
PUT
Viatris
VTRS
$20.8B
$223K 0.03%
20,000
LYFT icon
157
CALL
Lyft
LYFT
$5.86B
$220K 0.03%
20,000
-10,000
-33% -$121K
ITW icon
158
CALL
Illinois Tool Works
ITW
$84.1B
$220K 0.03%
+1,000
New +$213K
TMO icon
159
Thermo Fisher Scientific
TMO
$214B
$220K 0.03%
+400
New +$212K
UTHR icon
160
United Therapeutics
UTHR
$26.1B
$209K 0.03%
+750
New +$189K
UVE icon
161
CALL
Universal Insurance Holdings
UVE
$1.26B
$201K 0.03%
+19,000
New +$193K
TRKA
162
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$196K 0.03%
+67,532
New +$372K
PAR icon
163
PUT
PAR Technology
PAR
$716M
$196K 0.03%
7,500
-3,900
-34% -$100K
PTCT icon
164
PTC Therapeutics
PTCT
$6.18B
$191K 0.03%
+5,000
New +$208K
RCUS icon
165
PUT
Arcus Biosciences
RCUS
$3.33B
$186K 0.03%
+9,000
New +$248K
MRTX
166
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$181K 0.03%
+4,000
New +$259K
ESPR
167
CALL
DELISTED
Esperion Therapeutics
ESPR
$175K 0.03%
+28,100
New +$201K
RCUS icon
168
CALL
Arcus Biosciences
RCUS
$3.33B
$172K 0.02%
+8,300
New +$228K
SQM icon
169
Sociedad Química y Minera de Chile
SQM
$19.3B
$160K 0.02%
2,000
BSTZ icon
170
BlackRock Science and Technology Term Trust
BSTZ
$1.83B
$156K 0.02%
+10,000
New +$170K
GH icon
171
CALL
Guardant Health
GH
$19.1B
$150K 0.02%
5,500
-100
-2% -$4.58K
UWMC icon
172
CALL
UWM Holdings
UWMC
$672M
$147K 0.02%
44,400
SLB icon
173
SLB Ltd
SLB
$72.7B
$134K 0.02%
2,500
-90,000
-97% -$4.48M
NNDM
174
Nano Dimension
NNDM
$314M
$115K 0.02%
50,000
RCUS icon
175
Arcus Biosciences
RCUS
$3.33B
$103K 0.01%
+5,000
New +$138K

Similar funds

SG3 Management's Q4 2022 Portfolio in Review

As of Q4 2022, SG3 Management held 382 positions worth $693M, down 7.1% from $746M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

SG3 Management's Q4 2022 filing shows 110 new, 31 increased, 28 reduced and 176 closed positions. Its largest new stake was Alphabet (Google) Class A: 232,500 shares worth $20.5M. The largest sale was Tesla, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 3.7% a quarter earlier, followed by Communication Services and Healthcare.

  • SG3 Management's largest Q4 2022 buy was Alphabet (Google) Class A: 232,500 shares worth $20.5M.
  • SG3 Management added most to Microsoft in Q4 2022, an estimated $85.8M increase.
  • SG3 Management's biggest Q4 2022 reduction was Tesla, cutting an estimated $32.7M.
  • SG3 Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $18.7M.
  • SG3 Management's ten largest holdings make up 46% of its $693M portfolio in Q4 2022.
  • SG3 Management opened 110 new positions and closed 176 in Q4 2022.
  • SG3 Management's portfolio value fell 7.1% quarter-over-quarter to $693M.

Based on SG3 Management's 13F filing for Q4 2022, filed 14 Feb 2023.